Skip to main content

Table 2 Responses to primary and secondary outcomes measures at 2–6, 12, and 18 weeks post-discharge are provided

From: Prospective telehealth analysis of functional performance, frailty, quality of life, and mental health after COVID-19 hospitalization

 

Weeks 2–6

Week 12

Week 18

Interview Calls Completed

N = 101

N = 67

N = 63

10-Time Chair Rise Testa

 Mean [95% CI] seconds; N

29 [26, 32]; N = 73

25 [22, 28]; N = 50

21 [19, 23]; N = 43

 Unable to complete due to physical ability or safety concerns, % (n/total)

16% (16/101)

12% (8/67)

11% (7/63)

 Refused test (inconvenient), % (n/total)

12% (12/101)

13% (9/67)

21% (13/63)

MRC Dyspnea

 Dyspnea only with strenuous exercise or when hurrying, % (n/total)

38% (38/101)

64% (43/67)

71% (45/63)

 Walking slower than most people or stopping on level ground due to dyspnea, % (n/total)

37% (37/101)

21% (14/67)

17% (11/63)

 Dyspnea upon dressing and/or dyspnea that prevented them from leaving the house, % (n/total)

26% (26/101)

15% (10/67)

11% (7/63)

Supplemental O2 Use

 % (n/total)

40% (40/101)

27% (18/67)

29% (18/63)

Therapy

 In-home care, % (n/total)

3% (3/101)

3% (2/67)

0% (0/63)

 Outpatient PT and/or OT, % (n/total)

10% (10/101)

3% (2/67)

11% (7/63)

 

Weeks 2–6

Week 12

Week 18

Survey Form (one or more section completed)

N = 69

N = 56

N = 59

Reported Clinical Frailty Scale scorea

 Pre-frail/frail score, % (n/total)

77% (51/66)

59% (33/56)

51% (30/59)

 Return to pre-hospitalized level, % (n/total)

33% (21/64)

55% (27/49)

60% (29/48)

IES-6

 Probable PTSD, % (n/total)

45% (31/69)

20% (11/56)

22% (13/59)

 No PTSD, % (n/total)

55% (38/69)

80% (45/56)

78% (46/59)

WHODAS 2.0

 Mean [95% CI]; N

15 [12, 17]; N = 66

9 [6, 11]; N = 56

7 [5, 9]; N = 59

Reported exercise

 Return to pre-hospitalization level, % (n/total)

(Unavailable)b

63% (29/46)

69% (31/45)

  1. aPrimary outcome; bdata collected at weeks 12 and 18 only